Howard Fillit

15.2k total citations · 1 hit paper
85 papers, 5.6k citations indexed

About

Howard Fillit is a scholar working on Psychiatry and Mental health, Molecular Biology and Cell Biology. According to data from OpenAlex, Howard Fillit has authored 85 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Psychiatry and Mental health, 18 papers in Molecular Biology and 14 papers in Cell Biology. Recurrent topics in Howard Fillit's work include Dementia and Cognitive Impairment Research (23 papers), Health Systems, Economic Evaluations, Quality of Life (14 papers) and Proteoglycans and glycosaminoglycans research (13 papers). Howard Fillit is often cited by papers focused on Dementia and Cognitive Impairment Research (23 papers), Health Systems, Economic Evaluations, Quality of Life (14 papers) and Proteoglycans and glycosaminoglycans research (13 papers). Howard Fillit collaborates with scholars based in United States, Sweden and France. Howard Fillit's co-authors include Jill Kalman, Milton Packer, Beth Levine, Lloyd Mayer, Jerrold Hill, Luc Buée, Wanhong Ding, Robert Futterman, John B. Zabriskie and Larry D. Altstiel and has published in prestigious journals such as New England Journal of Medicine, The Journal of Experimental Medicine and Blood.

In The Last Decade

Howard Fillit

84 papers receiving 5.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Elevated Circulating Levels of Tumor Necrosis Factor in Severe Chronic Heart Failure

1990 2.1k citations Howard Fillit et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Howard Fillit United States	33	1.4k	1.2k	1.2k	909	507	85	5.6k
Annlia Paganini‐Hill United States	55	697 0.5×	1.7k 1.4×	1.2k 1.0×	1.1k 1.3×	453 0.9×	195	11.6k
Akihisa Iguchi Japan	55	1.2k 0.8×	2.3k 1.9×	1.9k 1.7×	670 0.7×	503 1.0×	311	9.2k
Elisabeth Steinhagen‐Thiessen Germany	40	779 0.5×	1.2k 1.0×	771 0.7×	455 0.5×	442 0.9×	294	6.0k
Kenji Toba Japan	38	1.4k 1.0×	2.0k 1.6×	804 0.7×	1.1k 1.2×	541 1.1×	184	6.3k
Rodney C.P. Go United States	36	795 0.5×	1.9k 1.6×	1.4k 1.2×	1.2k 1.3×	205 0.4×	120	7.0k
Majon Muller Netherlands	45	1.2k 0.8×	1.7k 1.4×	1.1k 0.9×	1.0k 1.1×	193 0.4×	165	6.5k
David Gaist Denmark	42	919 0.6×	693 0.6×	475 0.4×	1.1k 1.2×	253 0.5×	149	5.6k
Robyn L. Woods Australia	37	1.4k 1.0×	820 0.7×	741 0.6×	628 0.7×	282 0.6×	292	5.0k
Simon P. Mooijaart Netherlands	41	937 0.6×	1.2k 1.0×	742 0.6×	388 0.4×	558 1.1×	254	5.9k
Michael Davidson United States	39	610 0.4×	771 0.6×	906 0.8×	1.4k 1.5×	213 0.4×	121	7.0k

Countries citing papers authored by Howard Fillit

Since Specialization

Citations

This map shows the geographic impact of Howard Fillit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Howard Fillit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Howard Fillit more than expected).

Fields of papers citing papers by Howard Fillit

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Howard Fillit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Howard Fillit. The network helps show where Howard Fillit may publish in the future.

Co-authorship network of co-authors of Howard Fillit

This figure shows the co-authorship network connecting the top 25 collaborators of Howard Fillit. A scholar is included among the top collaborators of Howard Fillit based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Howard Fillit. Howard Fillit is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bereczki, Erika, Francesca Mangialasche, Mariagnese Barbera, et al.. (2025). Risk reduction and precision prevention across the Alzheimer’s disease continuum: a systematic review of clinical trials combining multidomain lifestyle interventions and pharmacological or nutraceutical approaches. The Journal of Prevention of Alzheimer s Disease. 12(10). 100367–100367.

Lyketsos, Constantine G., Andre Quina, Pierre N. Tariot, et al.. (2022). Standardizing Electronic Health Record Data on AD/ADRD to Accelerate Health Equity in Prevention, Detection, and Treatment. The Journal of Prevention of Alzheimer s Disease. 9(3). 556–560. 3 indexed citations

Fillit, Howard, et al.. (2020). Artificial Intelligence–Powered Digital Health Platform and Wearable Devices Improve Outcomes for Older Adults in Assisted Living Communities: Pilot Intervention Study. JMIR Aging. 3(2). e19554–e19554. 35 indexed citations

Fillit, Howard, et al.. (2020). Real-Time Digital Contact Tracing: Development of a System to Control COVID-19 Outbreaks in Nursing Homes and Long-Term Care Facilities. JMIR Public Health and Surveillance. 6(3). e20828–e20828. 26 indexed citations

Winblad, Bengt, Ariane K. Kawata, Kathleen Beusterien, et al.. (2007). Caregiver preference for rivastigmine patch relative to capsules for treatment of probable Alzheimer's disease. International Journal of Geriatric Psychiatry. 22(5). 485–491. 86 indexed citations

Lu, Shaoli, Jerrold Hill, & Howard Fillit. (2005). Impact of donepezil use in routine clinical practice on health care costs in patients with Alzheimer's disease and related dementias enrolled in a large medicare managed care plan: A case-control study. The American journal of geriatric pharmacotherapy. 3(2). 92–102. 16 indexed citations

Fillit, Howard, Jerrold Hill, & Robert Futterman. (2003). Health care utilization and costs of Alzheimer's disease: the role of co-morbid conditions, disease stage, and pharmacotherapy.. PubMed. 34(7). 528–35. 80 indexed citations

Fillit, Howard, et al.. (2002). Optimizing Coding and Reimbursement to Improve Management of Alzheimer's Disease and Related Dementias. Journal of the American Geriatrics Society. 50(11). 1871–1878. 82 indexed citations

Rice, Dorothy P., Howard Fillit, Wendy Max, et al.. (2001). Prevalence, costs, and treatment of Alzheimer's disease and related dementia: a managed care perspective.. PubMed. 7(8). 809–18. 96 indexed citations

10.

Yu, Haini, D.J. Tyrrell, Neng‐Hua Guo, et al.. (2000). Specificities of Heparin-binding Sites from the Amino-Terminus and Type 1 Repeats of Thrombospondin-1. Archives of Biochemistry and Biophysics. 374(1). 13–23. 27 indexed citations

11.

Fillit, Howard, Elane M. Gutterman, & Barbara Lewis. (1999). Donepezil use in managed medicare: Effect on health care costs and utilization. Clinical Therapeutics. 21(12). 2173–2185. 32 indexed citations

12.

Fillit, Howard & Robert N. Butler. (1997). Cognitive decline : strategies for prevention. 18 indexed citations

13.

Leveugle, Béatrice, et al.. (1995). Interleukin-1 and nerve growth factor induce hypersecretion and hypersulfation of neuroblastoma proteoglycans which bind β-amyloid. Journal of Neuroimmunology. 60(1-2). 151–160. 5 indexed citations

14.

Fillit, Howard. (1995). Future Therapeutic Developments of Estrogen Use. The Journal of Clinical Pharmacology. 35(9S). 25S–28S. 8 indexed citations

15.

Shibata, S, P C Harpel, A E Gharavi, Jacob H. Rand, & Howard Fillit. (1994). Autoantibodies to heparin from patients with antiphospholipid antibody syndrome inhibit formation of antithrombin III-thrombin complexes [see comments]. Blood. 83(9). 2532–2540. 94 indexed citations

16.

Shibata, S, T. Sasaki, Peter C. Harpel, & Howard Fillit. (1994). Autoantibodies to Vascular Heparan Sulfate Proteoglycan in Systemic Lupus Erythematosus React with Endothelial Cells and Inhibit the Formation of Thrombin-Antithrombin III Complexes. Clinical Immunology and Immunopathology. 70(2). 114–123. 30 indexed citations

17.

Dimitriu-Bona, A. & Howard Fillit. (1993). Studies of the Cellular Immune Response to Heparan Sulfate Proteoglycan in the Tight Skin Mouse. Cellular Immunology. 150(2). 321–332. 5 indexed citations

18.

Fillit, Howard, et al.. (1993). Studies of Hospital Social Stays in the Frail Elderly and Their Relationship to the Intensity of Social Work Intervention. Social Work in Health Care. 18(1). 1–22. 20 indexed citations

19.

Fields, Suzanne, et al.. (1992). Usefulness of the Neurobehavioral Cognitive Status Examination in the Hospitalized Elderly. International Psychogeriatrics. 4(1). 93–102. 36 indexed citations

20.

Fillit, Howard, et al.. (1988). Immunogenicity of liposome-bound hyaluronate in mice. At least two different antigenic sites on hyaluronate are identified by mouse monoclonal antibodies.. The Journal of Experimental Medicine. 168(3). 971–982. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact